Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
09/13/2001 | WO2001066796A1 Method and system for the simultaneous and multiple detection and quantification of the hybridization of molecular compounds such as nucleic acids, dna, rna, pna and proteins |
09/13/2001 | WO2001066795A1 Method for analysing the length of a nucleic acid molecule |
09/13/2001 | WO2001066794A1 Molecular methods for detecting guar gum additions to locust bean gum |
09/13/2001 | WO2001066791A1 Method of screening inducible nitric oxide synthase activation inhibitor |
09/13/2001 | WO2001066789A1 Rapid screening procedure for inflammation mediators |
09/13/2001 | WO2001066787A1 Improved reverse n-hybrid screening method |
09/13/2001 | WO2001066786A1 Methods of diagnosing and monitoring endometrial glandular development |
09/13/2001 | WO2001066762A1 Human extracellular signal regulated kinases |
09/13/2001 | WO2001066754A1 Human antibodies against eotaxin and their use |
09/13/2001 | WO2001066746A2 G-protein coupled receptor related polypeptides |
09/13/2001 | WO2001066742A2 G-protein coupled receptors |
09/13/2001 | WO2001066741A2 Kcnb: a novel potassium channel protein |
09/13/2001 | WO2001066740A2 Compositions and methods for the treatment of immune related diseases |
09/13/2001 | WO2001066732A1 Human abc transporter expressed in liver, atil |
09/13/2001 | WO2001066722A1 Immune system-related polynucleotides, polypeptides, and antibodies |
09/13/2001 | WO2001066719A1 Novel gene cloned in human neuroblastoma and novel gene fragments |
09/13/2001 | WO2001066716A1 Polypeptide having phosphodiesterase activity |
09/13/2001 | WO2001066708A2 MATERIALS AND METHODS RELATING TO THE DEGRADATION OF Cdc25A IN RESPONSE TO DNA DAMAGE |
09/13/2001 | WO2001066706A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
09/13/2001 | WO2001066597A2 Inflammation-related gene |
09/13/2001 | WO2001066593A1 Structural coordinate of protein complex and utilization of the structural coordinate |
09/13/2001 | WO2001066572A2 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
09/13/2001 | WO2001066568A2 Use of recombinant antigens to determine the immune status of an animal |
09/13/2001 | WO2001066563A2 T1r taste receptors and genes encoding same |
09/13/2001 | WO2001066557A1 Adam polynucleotides, polypeptides, and antibodies |
09/13/2001 | WO2001066521A1 Azacyclic compounds for use in the treatment of serotonin related diseases |
09/13/2001 | WO2001066486A1 Control of ammonia emission from ammonia-laden fly ash in concrete |
09/13/2001 | WO2001066244A1 Materials with silicon-containing layers for use in miniaturized arrays and methods of manufacturing |
09/13/2001 | WO2001066242A2 Device and method for performing syntheses, analyses or transport processes |
09/13/2001 | WO2001066227A2 Method and device for quickly and continually detecting changes in the concentration of radon gas that is dissolved in water |
09/13/2001 | WO2001066172A2 Extracorporeal blood processing method and apparatus |
09/13/2001 | WO2001066152A1 Simultaneous multimodal measurement of physiological function |
09/13/2001 | WO2001066139A1 Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cell |
09/13/2001 | WO2001066134A1 Rfrp-containing prolactin secretion regulatory agent |
09/13/2001 | WO2001066128A1 Methods of regulating cytokine signalling |
09/13/2001 | WO2001066126A1 Sialoadhesin factor-2 antibodies |
09/13/2001 | WO2001066116A1 Method for modulating tumor growth and metastasis of tumor cells |
09/13/2001 | WO2001066113A1 Metabotropic glutamate receptor antagonists for treating tolerance and dependency |
09/13/2001 | WO2001066107A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
09/13/2001 | WO2001066000A2 Health analysis and forecast of abnormal conditions |
09/13/2001 | WO2001065998A2 Methods for the diagnosis and treatment of breast cancer |
09/13/2001 | WO2001029178A3 Epo primary response gene 1, eprg1 |
09/13/2001 | WO2001018545A3 Method for identifying binding partners with position-specific arrays |
09/13/2001 | WO2001016288A3 Dna encoding the human serine protease c-e |
09/13/2001 | WO2001015593A3 Compositions for reducing vascular plaque formation and methods of using same |
09/13/2001 | WO2001011010A3 Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene |
09/13/2001 | WO2001005480A3 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor |
09/13/2001 | WO2001004343A9 A method for determining the prognosis of cancer patients by measuring levels of bag expression |
09/13/2001 | WO2001000865A3 Amperometric sensor |
09/13/2001 | WO2000073797A3 Homogeneous tests for sequentially determining lipoprotein fractions |
09/13/2001 | WO2000072019A3 Liposome-enhanced test device and method |
09/13/2001 | WO2000063370A3 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes |
09/13/2001 | WO2000060120A3 Methods of detecting microorganism using immobilized probes |
09/13/2001 | WO2000059886A3 Benzimidazole abd imidazolophyridine derivaties, their preparation and their use as selective modulators of bradykinin b2 (=bk-2) receptors |
09/13/2001 | WO2000043790A9 Compositions and methods for the diagnosis and treatment of tumor |
09/13/2001 | WO2000040331A9 Apparatus and method for combinatorial research for catalysts and polymers |
09/13/2001 | WO2000039336A9 Methods of characterizing drug activities using consensus profiles |
09/13/2001 | WO2000034780A8 METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ¿3? |
09/13/2001 | WO1995021922A3 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use |
09/13/2001 | WO1995005604A3 Methods for the diagnosis of alzheimer's disease |
09/13/2001 | US20010021816 Estrogen or estradiol need determination by vaginal or urethral acidity determination |
09/13/2001 | US20010021815 Breath test analyzer |
09/13/2001 | US20010021771 Human doppel polypeptide; genetic engineering |
09/13/2001 | US20010021713 Thromboresistant materials incorporating pyrazinone protease inhibitors |
09/13/2001 | US20010021702 Newly identified polypeptides and polynucleotides that encode them; used in identifying compounds which may be agonists, antagonists and/or inhbitors which are can be useful in therapy |
09/13/2001 | US20010021700 Vectors, host cells, antibodies, and recombinant and synthetic methods for producing polynucleotides and the polypeptides they encode |
09/13/2001 | US20010021536 Even fluid front for liquid sample on test strip device |
09/13/2001 | US20010021535 Detecting and/or quantifying anibody and antigen analytes using affinity capture; quantification by normalizing and calibrating the obtained mass spectrum against the mass spectrum obtained for known antibody/antigen concentrations |
09/13/2001 | US20010021534 Multi-array, multi-specific electrochemiluminescence testing |
09/13/2001 | US20010021533 Multi-partite ligands and methods of identifying and using same |
09/13/2001 | US20010021532 Using cells comprising promoters having an AP1 site linked to a reporter gene so compounds capable of blocking or inducing expression of the reporter gene can be identified |
09/13/2001 | US20010021531 Food contamination detection system for vacuum packaged food products |
09/13/2001 | US20010021526 Immortal rho degrees cell line; undifferentiated cells for drug screening; alzheimers, huntington's disease, myoclonic epilepsy lactic acidosis and stroke (MELAS); myoclonic epilepsy ragged red fiber (MERRF) |
09/13/2001 | US20010021517 An isolated nucleic acid molecule that hybridizes under stringent hybridization conditions with macrophase migration inhibiatory factor (MIF) gene selected from dirofilaria immitis MIF gene and Onchocerca volvulus MIF gene |
09/13/2001 | US20010021513 Used for carrying out the bio- or immuno- chemical test such as a pepscan or enzyme-linked immunosorbent assay |
09/13/2001 | US20010021512 Microsporidian polar tube proteins, nucleic acids coding for these proteins and their applications |
09/13/2001 | US20010021511 Contacting a stool sample obtained from the mammal with a capture reagent ( an antibody) which binds to a 29 KDa antigen of Entamoeba histolytica to form a complex with 29 KDa antigen if present in the stool sample |
09/13/2001 | US20010021510 Materials and methods for detection and treatment of immune system dysfunctions |
09/13/2001 | US20010021508 Methods of diagnosing renal salt wasting syndrome and alzheimer's disease and methods of treating the same |
09/13/2001 | US20010021507 Renal nuclear matrix protein able to differentiate cancerous renal cell from normal renal cells; useful for diagnosis and producing treatment for cell proliferative disorders of the kidney |
09/13/2001 | US20010021506 The functionalized silicon compound containing one or more derivatizable functional group selected from the group consisting of hydroxyl, amino, amido, carboxyl, thio, halo and sulfonate, and one or more acativated silicon group |
09/13/2001 | US20010021503 Oligomeric carrier molecules with defined incorporated marker groups and haptens |
09/13/2001 | US20010021501 Providing a sample suspected of containing enterovirus and a mixed cell culture comprising at least two cell types which are RD cells and human mucoepidermoid cells, incubating the culture with sample to produce inoculated culture, observing |
09/13/2001 | US20010021500 Correction of genetic defects using chemical chaperones |
09/13/2001 | US20010021383 Antibodies for diagnosis, therapy |
09/13/2001 | US20010021356 Storage |
09/13/2001 | US20010021355 Measuring blood coagulation time |
09/13/2001 | US20010020678 Device for delivery of multiple liquid sample streams to a mass spectrometer |
09/13/2001 | US20010020397 Sampler for melts |
09/13/2001 | US20010020396 Sampler and method of dispensing and cooling a fluid |
09/13/2001 | US20010020383 Gas sensor |
09/13/2001 | DE19960919A1 Verfahren und Vorrichtung zur Messung optischer Parameter an flüssigen Medien Method and apparatus for measuring optical parameters of liquid media |
09/13/2001 | DE19856433C2 Verfahren zum spezifischen Nachweis von glykosilierten Proteinen A method for specific detection of glycosylated proteins |
09/13/2001 | DE10113355A1 Chemical sensor used for the qualitative or quantitative detection of mercury consists of a receptor layer covered by one or more organic layers |
09/13/2001 | DE10109676A1 Nitrogen oxides detection device comprises an oxygen pump cell for removing oxygen from measuring gas, and a detection cell for measuring nitrogen oxides contained in the measuring gas from which oxygen is removed |
09/13/2001 | DE10109259A1 Characterizing increased dedifferentiation of cancer cells useful for diagnosing cancer, particularly early cervical cancer, comprises applying body fluids to a foil covered slide and detecting dye-marked cells by laser |
09/13/2001 | DE10011822A1 Filterless unit for on-line measurement of fluids comprises valve controlled capillary system, inert gas injection and photo cell |
09/13/2001 | DE10011254A1 Method for identifying polyamide 6 and polyamide 6.6 in carpet pile before recycling, comprises cleaning with high pressure water or steam, drying with compressed air, optionally cooling and analysis using raman spectroscopy |
09/13/2001 | DE10011164A1 Process for determining the hydrogen concentration in fluid media comprises using a sensor consisting of a supported hydrogen activated metal and a hydrogen storing support material provided with two connecting electrodes |
09/13/2001 | DE10011163A1 System for detection of albumin transport properties, induces targeted conformation changes in samples for electron spin resonance spectrometry for accurate early warning of changes in the patient or product |